Slides | Diabetes and cardiovascular risk
EPCCS 2019 Slides prepared and presented by prof. Kamlesh Khunti (Leicester, UK) here offered as an educational service.
More on Diabetes
11 minCardiorenal risk management in Primary care: Panel Discussion
11 minOptimising Management with SGLT-2i-based Strategies in Primary Care
9 minThe Foundation of Cardiorenal Protection: What the Guidelines Say
CKD; New ESC Guidelines: Every Patient with Heart Disease Should Now Be Tested for Kidney Disease
Global guideline on the use of GLP-1 medicines in treating obesity issued by WHO
EU Launches Ambitious "Safe Hearts Plan": A New Roadmap in Cardiovascular HealthCurrent Medical Therapy in Epicardial and Microvascular DiseaseStroke in the YoungPerioperative management of SGLT2 inhibitorsGlucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice.
Global guideline on the use of GLP-1 medicines in treating obesity issued by WHOEU Launches Ambitious "Safe Hearts Plan": A New Roadmap in Cardiovascular HealthCurrent Medical Therapy in Epicardial and Microvascular DiseaseStroke in the YoungPerioperative management of SGLT2 inhibitorsGlucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice.